Sophie Gautier Selected Research

Baclofen

12/2019	A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
5/2019	Acute Psychosis Related to Baclofen in a Patient Treated for Binge Eating Disorder Highlights the Urgent Need to Regulate Off-Label Prescriptions.
4/2018	On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
2/2017	Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
1/2017	Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
1/2017	The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.
1/2017	Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.
10/2015	Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation.
4/2015	Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.
3/2015	[Temporary recommendation for use on off-label baclofen: viewpoint of Prescribers of the CAMTEA system].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Gautier Research Topics

Disease

13	Alcoholism (Alcohol Abuse) 12/2019 - 03/2014
9	Drug-Related Side Effects and Adverse Reactions 04/2022 - 05/2013
9	Stroke (Strokes) 10/2021 - 11/2009
7	Infarction (Infarctions) 04/2017 - 12/2003
6	Hemorrhage 03/2022 - 12/2003
6	Ischemia 05/2014 - 12/2003
5	Ischemic Stroke 04/2017 - 01/2011
4	Brain Ischemia (Cerebral Ischemia) 06/2014 - 04/2005
3	Crohn Disease (Crohn's Disease) 11/2020 - 11/2014
3	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 06/2012
3	Cerebral Hemorrhage 01/2016 - 12/2003
2	COVID-19 04/2022 - 07/2021
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 02/2015
2	Atrial Fibrillation 10/2021 - 06/2012
2	Psychotic Disorders (Schizoaffective Disorder) 09/2021 - 05/2019
2	Thrombosis (Thrombus) 07/2021 - 01/2018
2	Neoplasms (Cancer) 12/2018 - 07/2005
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2017 - 01/2015
2	Pain (Aches) 04/2017 - 09/2013
2	Human Influenza (Influenza) 10/2016 - 09/2013
2	Infections 10/2016 - 01/2015
2	Hepatic Encephalopathy 03/2014 - 12/2009
2	Brain Infarction 02/2009 - 04/2005
1	Dysarthria (Spastic Dysarthria) 12/2022
1	Cluster Headache (Cluster Headaches) 04/2022
1	Cystic Fibrosis (Mucoviscidosis) 03/2022
1	Sleep Wake Disorders 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Angioedema 01/2022
1	Hereditary Angioedemas 01/2022
1	Myocarditis (Carditis) 01/2022
1	Pericarditis 01/2022
1	Diabetes Mellitus 11/2021
1	Embolism (Embolus) 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Cognitive Dysfunction 01/2021
1	Rhabdomyolysis 11/2020
1	Muscle Weakness 11/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2020
1	Mental Disorders (Mental Disorder) 10/2020
1	Rheumatoid Arthritis 01/2020
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2020
1	Eosinophilia 01/2020
1	Osteoporosis 12/2019
1	Osteomalacia 12/2019
1	Chronic Disease (Chronic Diseases) 12/2019
1	Binge-Eating Disorder (Binge Eating Disorder) 05/2019
1	Hyperkalemia 01/2019

Drug/Important Bio-Agent (IBA)

14	Baclofen FDA LinkGeneric 12/2019 - 03/2014
10	Pharmaceutical PreparationsIBA 12/2022 - 01/2004
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 12/2003
4	VaccinesIBA 01/2022 - 09/2013
4	Neuroprotective AgentsIBA 06/2014 - 11/2004
3	Vitamin K FDA Link 10/2021 - 06/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 11/2014
3	Adalimumab (Humira)FDA Link 11/2020 - 05/2013
3	Antidepressive Agents (Antidepressants)IBA 10/2020 - 10/2014
3	Fenofibrate (CiL)FDA LinkGeneric 01/2015 - 11/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015 - 06/2013
2	BNT162 VaccineIBA 04/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 07/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2016
2	Dabigatran FDA Link 10/2021 - 06/2012
2	RivaroxabanIBA 10/2021 - 01/2018
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 06/2014
2	CholesterolIBA 01/2021 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 12/2019
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 01/2015
2	agomelatine (S20098)IBA 10/2018 - 09/2013
2	Misoprostol (Cytotec)FDA LinkGeneric 12/2016 - 11/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 02/2009 - 04/2005
1	Rosuvastatin Calcium (Crestor)FDA Link 12/2022
1	Aromatase InhibitorsIBA 04/2022
1	SteroidsIBA 04/2022
1	elexacaftorIBA 03/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 03/2022
1	ivacaftor drug combination tezacaftorIBA 03/2022
1	BenzodiazepinesIBA 01/2022
1	Histamine Antagonists (Antihistamines)IBA 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	MelatoninIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	BradykininIBA 01/2022
1	Nitrous Oxide (Laughing Gas)IBA 01/2022
1	AnticoagulantsIBA 10/2021
1	apixabanIBA 10/2021
1	Infliximab (Remicade)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 12/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2019
1	AntacidsIBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2005
6	Off-Label Use 04/2018 - 05/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2018
1	Immunotherapy 01/2022